Schleifer Leonard S 的 Form 4 申報
Regeneron Pharmaceuticals, Inc.（REGN），2024/6/13 申報
- 申報編號
- 0001104659-24-071247
- 申報時間
- 2024/6/13
- 交易日
- 2024/6/11-6/12
- 申報延遲
- 2 天
- 10b5-1 計畫
- 有勾選
這份申報列了 6 筆非衍生性交易、1 筆衍生性交易。公開市場賣出合計 $2,561 萬。交易後 2 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Schleifer Leonard SCIK 0001218629 | 董事、高階主管（Bd. Co-Chair, President & CEO） |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2024/6/11 | Common Stock | S賣出處分 | −7,321 | $1,015.28F2 | −$7,432,864.88 | 56,877 | 間接 | |
| 2024/6/11 | Common Stock | S賣出處分 | −1,743 | $1,016.04F3 | −$1,770,957.72 | 55,134 | 間接 | |
| 2024/6/12 | Common Stock | S賣出處分 | −14,879 | $1,015.30F4 | −$15,106,648.7 | 40,255 | 間接 | |
| 2024/6/12 | Common Stock | S賣出處分 | −270 | $1,016.62F5 | −$274,487.4 | 39,985 | 間接 | |
| 2024/6/12 | Common Stock | C轉換取得 | +1,000 | $0.00 | $0 | 1,000 | 間接 | |
| 2024/6/12 | Common Stock | S賣出處分 | −1,000 | $1,025.27F6 | −$1,025,270 | 0 | 間接 |
衍生性證券（表 II）
選擇權、認股權證、限制型股票單位等。股數是標的股票的股數；單價與金額是衍生證券本身的價格，交易後持有是衍生證券的單位數。
| 交易日 | 證券 | 交易 | 標的股數 | 單價 | 金額 | 交易後持有 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2024/6/12 | Common Stock | C轉換處分 | −1,000 | $0.00 | $0 | 14,775 | 間接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F2
Represents volume-weighted average price of sales of 7,321 shares of common stock of Regeneron Pharmaceuticals, Inc. (the "Company") on June 11, 2024 at prices ranging from $1,015.00 to $1,015.85. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 11, 2024 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F3
Represents volume-weighted average price of sales of 1,743 shares of Company stock on June 11, 2024 at prices ranging from $1,016.04 to $1,016.10. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 11, 2024 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F4
Represents volume-weighted average price of sales of 14,879 shares of Company stock on June 12, 2024 at prices ranging from $1,015.00 to $1,015.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 12, 2024 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F5
Represents volume-weighted average price of sales of 270 shares of Company stock on June 12, 2024 at prices ranging from $1,016.10 to $1,016.80. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 12, 2024 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F6
Represents volume-weighted average price of sales of 1,000 shares of Company stock on June 12, 2024 at prices ranging from $1,025.00 to $1,025.55. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 12, 2024 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。